Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 249

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 249
---
, a venture capital firm specializing in early
stage investments, as a venture partner. Mr. Patel was a partner at, and served on the executive committee of, Hexagon Securities, LLC,
a credit focused investment bank and securities firm from 2010 to 2012. From 2001 to August 2009, he served as Managing Director and
Senior Partner at Cohen & Company, where he helped launch Alesco Financial, Inc. (NYSE: AFN), where he served as Chief Operating
Officer and Chief Investment Officer from 2006 to 2009. From 1999 to 2000, he served as Chief Financial Officer for TRM Corporation (NASDAQ:
TRMM), a consumer and financial services company. In 2000, Mr. Patel co-founded iATMglobal.net, a middleware software business where
he served as Chief Executive Officer and which was sold to NCR Corporation in 2001. He served as Vice President of the West Coast Region
for Sirrom Capital Corporation, a mezzanine finance fund, from 1998 to 1999. Prior to this he was in the business services group at Robertson
Stephens, an investment banking firm, from 1997 to 1998 and served as a strategy consultant in the energy group at Andersen Consulting
(now known as Accenture plc) from 1991 to 1993. Mr. Patel served on the Board of Visitors of Duke University School of Law from 2011
to 2023 where he was a Senior Lecturing Fellow. Mr. Patel received a Juris Doctor with honors and Master of Business Administration from
Duke University and Bachelor of Arts in Philosophy and Economics from Trinity University.

<div align='center'>144</div>

Mr. Patel was selected to
serve on our board of directors based on his extensive investment, leadership and operational experience.

Family Relationships

There are no family relationships
between our board of directors and any of our executive officers.

Board of Directors

Director Independence

Nasdaq listing rules require
that a majority of the board of directors of a company listed on Nasdaq be composed of “independent directors,” which is
defined generally as a person other than an officer or employee of a company or its subsidiaries or any other individual having a relationship,
which, in the opinion of such company’s board of directors, would interfere with the director’s exercise of independent judgment
in carrying out the responsibilities of a director. Based on business and personal information provided by each director